Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

12

Revenue 2017

Seretide/Advair

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Seretide/Advair was produced by GlaxoSmithKline.

GSK seeks EU approval for Trelegy in adult asthma patients

GSK seeks EU approval for Trelegy in adult asthma patients

GSK’s respiratory business has been hit with the loss of patent protection for its COPD blockbuster Seretide/Advair (fluticasone propionate/salmeterol) – Trelegy is GSK’s answer to the increased competition

GSK considers more divestments to help R&D push

GSK considers more divestments to help R&D push She said it was encouraging that in the year that generic competition really bit hard into sales of GSK’s longstanding respiratory blockbuster Advair/Seretide (fluticasone propionate/salmeterol), the group was

GSK divests travel vaccines to Bavarian Nordic as part of strategic refocus

GSK divests travel vaccines to Bavarian Nordic as part of strategic refocus The revamp at GSK was needed in large part due to generic competition to its blockbuster respiratory treatment Advair.

Novartis strengthens case for its combination asthma drug

Novartis strengthens case for its combination asthma drug The respiratory market has been largely dominated by GlaxoSmithKline, but its been facing generic competition for its ageing asthma blockbuster Advair.

GSK boosts outlook thanks to strong respiratory and vaccine sales

GSK boosts outlook thanks to strong respiratory and vaccine sales This offset the decline of its established pharmaceuticals – this includes its respiratory medicine Advair, which recently lost patent protection.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics